Source comparison
Best BPC-157 Dosage Tissue Repair 2026: Protocol Comparison
The table below compares dosing protocols based on injury type, dosing frequency, and expected repair timelines. Tendon strain (Achilles, patellar, rotator cuff) 250–350mcg Twice daily Within 2–3cm of tendon insertion 4–8 weeks for partial tears; 8–12 weeks fo
This comparison does not assign a generated winner or score.
- The table below compares dosing protocols based on injury type, dosing frequency, and expected repair timelines.
- Tendon strain (Achilles, patellar, rotator cuff)
- 250–350mcg
- Twice daily
- Within 2–3cm of tendon insertion
- 4–8 weeks for partial tears; 8–12 weeks for severe strains
- Local injection at tendon-bone junction shows fastest healing; systemic dosing extends timeline by 30–50%
- Ligament injury (ACL, MCL, ankle sprains)
- 300–400mcg
- Proximal to ligament on accessible skin surface
- 6–10 weeks for grade I–II sprains; 12+ weeks for grade III
- Ligament healing is slower than tendon due to lower vascularization; BPC-157 accelerates early angiogenesis phase
- Muscle tear or strain
- 200–300mcg
- Once or twice daily
- Directly over muscle belly or proximal to tear
- 3–6 weeks depending on severity
- Muscle tissue heals faster than connective tissue; once-daily dosing often sufficient for minor strains
- Joint inflammation (bursitis, synovitis)
- 250mcg
- Once daily
- Near affected joint
- 2–4 weeks for acute inflammation
- Anti-inflammatory effects appear within days; continued dosing prevents recurrence during rehab phase
- Bone fracture or stress fracture
- Closest accessible site to fracture
- 6–12 weeks (adjunct to immobilization)
- BPC-157 supports periosteal healing and callus formation but does not replace mechanical stability requirements
- Post-surgical repair (orthopedic)
- Incision-proximal or drain site if applicable
- 4–8 weeks post-op
- Early initiation (within 48 hours post-surgery) shows best outcomes; delays reduce benefit